RHON-KLINIKUM AG has announced a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, a slight increase from EUR 833.5 million in the prior year period. EBITDA rose to EUR 57.0 million from EUR 46.7 million, and consolidated profit improved to EUR 22.5 million from EUR 14.7 million. The results were partially impacted by immediate transformation costs established to offset higher personnel and material costs in previous years.
The company treated a total of 513,700 patients on an outpatient and inpatient basis from January to June, marking a 9% increase compared to 471,295 patients in the first half of 2025. This growth reflects the ongoing expansion and improvement of regional healthcare provision across its sites. Major investments in state-of-the-art medical technology are planned for 2026, alongside the further development of medical and therapeutic care offerings and the establishment of regional cooperation networks.
In Hesse, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have formed a strategic partnership to enhance the care of lung patients. In Brandenburg, the newly opened child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site is part of a growing regional network. Cooperation agreements with the City of Frankfurt (Oder) and the District of Oder-Spree aim to ensure seamless coordination for affected children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs.” He stressed that collaboration across providers is essential to ensure comprehensive and high-quality care, especially in rural areas.
Dr. Stefan Stranz, also a Board member, expressed concerns about the regulatory environment: “The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
Looking ahead to the full year 2026, RHON-KLINIKUM expects revenues of EUR 1.7 billion, within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also monitors non-financial indicators such as number of cases and cost weights, expecting moderate improvements.
However, the financial year will be significantly impacted by ongoing legislative changes, particularly the Hospital Reform Adjustment Act (KHAG) and the Statutory Health Insurance (SHI) Contribution Rate Stabilisation Act (GKV-BStabG), which aim to enhance quality and efficiency but may increase financial pressure on hospitals in the short term. The forecast is subject to uncertainties due to regulatory interference, implementation of hospital reform, global crises, and economic volatility.
